ClinConnect ClinConnect Logo
Search / Trial NCT06597929

Moderate-vigorous Intermittent Physical Activity (M-VILPA) in Stroke

Launched by UNIVERSITAT INTERNACIONAL DE CATALUNYA · Sep 13, 2024

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

Physical Activity Stroke Moderate Vigorous Physical Activity

ClinConnect Summary

This clinical trial is studying the effects of a specific type of physical activity called Moderate-vigorous Intermittent Physical Activity (M-VILPA) on people who have had a stroke. The goal is to see how this type of exercise can help stroke survivors who are living in the community and are in the late recovery phase after their hospital stay. Regular physical activity is important for improving strength, balance, and overall health, but many stroke survivors tend to become less active after leaving the hospital. By encouraging these individuals to participate in M-VILPA, researchers hope to help them maintain their physical abilities and reduce the risk of further health issues.

To be eligible for this trial, participants must be adults aged 57 and older who have had a stroke confirmed by a doctor and have been discharged from the hospital. They should also be able to move independently. Unfortunately, those with other serious neurological conditions or severe leg injuries cannot participate. If selected, participants can expect to engage in guided physical activities designed to improve their health and well-being. This study is not yet recruiting, but it aims to provide valuable insights into how exercise can benefit stroke survivors in their daily lives.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • adults aged ≥57 in the late subacute phase post-stroke.
  • who live in the community
  • whose clinician confirmed a diagnosis of stroke (ischaemic/haemorrhagic)
  • discharged from hospital inpatient regimen
  • with independent mobility skills (Barthel Index ≥ 40 points).
  • Exclusion Criteria:
  • • other neurological diseases (e.g. Parkinson disease) or severe lower limb injuries.

About Universitat Internacional De Catalunya

The Universitat Internacional de Catalunya (UIC) is a prestigious higher education institution situated in Barcelona, Spain, renowned for its commitment to academic excellence and innovation in research. With a strong emphasis on interdisciplinary collaboration, UIC actively engages in clinical trials that aim to advance medical knowledge and improve patient outcomes. The university's dedicated research teams are equipped with cutting-edge facilities and experienced professionals, enabling them to conduct rigorous studies across various health-related fields. UIC's focus on ethical practices and compliance ensures that all clinical trials are conducted with the highest standards of scientific integrity and participant safety.

Locations

Patients applied

0 patients applied

Trial Officials

Rosa Cabanas-Valdés, PhD

Principal Investigator

Universitat Internacional de Catalunya

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported